Witold Szaflarski

[Interference RNA--molecular regulator of gene expression].

Dissecting the ribosomal inhibition mechanisms of edeine and pactamycin: the universally conserved residues G693 and C795 regulate P-site RNA binding.

Cell-free protein expression and functional assay in nanowell chip format.

The antibiotic kasugamycin mimics mRNA nucleotides to destabilize tRNA binding and inhibit canonical translation initiation.

Troubleshooting coupled in vitro transcription-translation system derived from Escherichia coli cells: synthesis of high-yield fully active proteins.

Question 7: optimized energy consumption for protein synthesis.

New features of the ribosome and ribosomal inhibitors: non-enzymatic recycling, misreading and back-translocation.

An unexpected type of ribosomes induced by kasugamycin: a look into ancestral times of protein synthesis?

Function and frustration of multi-drug ABC exporter protein and design of model proteins for drug delivery using protein hydration thermodynamics.

Increased risk of thyroid pathology in patients with thyroid hemiagenesis: results of a large cohort case-control study.

Elastic-contractile model proteins: Physical chemistry, protein function and drug design and delivery.

FOXE1 polyalanine tract length polymorphism in patients with thyroid hemiagenesis and subjects with normal thyroid.

Bacterial ribosome requires multiple L12 dimers for efficient initiation and elongation of protein synthesis involving IF2 and EF-G.

[The structure of cellular vaults, their role in the normal cell and in the multidrug resistance of cancer].

SOCS3 and SOCS5 mRNA expressions may predict initial steroid response in nephrotic syndrome children.

RsfA (YbeB) proteins are conserved ribosomal silencing factors.

Inhibitors of N-glycosylation as a potential tool for analysis of the mechanism of action and cellular localisation of glycoprotein P.

Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue.

Nuclear localization of P-glycoprotein is responsible for protection of the nucleus from doxorubicin in the resistant LoVo cell line.

Expression profiles of vault components MVP, TEP1 and vPARP and their correlation to other multidrug resistance proteins in ovarian cancer.

Expression of various insulin-like growth factor-1 mRNA isoforms in colorectal cancer.

Alternative 3' acceptor site in the exon 2 of human PAX8 gene resulting in the expression of unknown mRNA variant found in thyroid hemiagenesis and some types of cancers.

Vinca alkaloid drugs promote stress-induced translational repression and stress granule formation.

Mutations in proteasome-related genes are associated with thyroid hemiagenesis.